UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetics, pharmacodynamics, and safety of izuforant, an H4R inhibitor, in healthy subjects: A phase I single and multiple ascending dose study

Clinical and translational science, 2024-10, Vol.17 (10), p.e70032-n/a

2024

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic drug–drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers

Clinical and translational science, 2023-08, Vol.16 (8), p.1469-1478

2023

Volltextzugriff (PDF)

Comparative Pharmacokinetic Analysis of Thiamine and Its Phosphorylated Metabolites Administered as Multivitamin Preparations

Clinical therapeutics, 2016-10, Vol.38 (10), p.2277-2285

2016

Volltextzugriff (PDF)

Population Pharmacokinetic Analysis of Piperacillin in Burn Patients

Antimicrobial agents and chemotherapy, 2014-07, Vol.58 (7), p.3744-3751

2014

Volltextzugriff (PDF)

Population Pharmacokinetic Analysis of Colistin in Burn Patients

Antimicrobial Agents and Chemotherapy, 2013-05, Vol.57 (5), p.2141-2146

2013

Volltextzugriff (PDF)

Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects

Translational and Clinical Pharmacology, 2023, 31(1), , pp.59-68

2023

Volltextzugriff (PDF)

Bortezomib pharmacokinetics in tumor response and peripheral neuropathy in multiple myeloma patients receiving bortezomib-containing therapy

Anti-cancer drugs, 2017-07, Vol.28 (6), p.660-668

2017

Volltextzugriff (PDF)

Use of a Target‐Mediated Drug Disposition Model to Predict the Human Pharmacokinetics and Target Occupancy of GC1118, an Anti‐epidermal Growth Factor Receptor Antibody

Basic & clinical pharmacology & toxicology, 2017-03, Vol.120 (3), p.243-249

2017

Volltextzugriff (PDF)

Application of target-mediated drug disposition model to predict human pharmacokinetics and target occupancy of GC1118, an anti-epidermal growth factor receptor antibody

Drug metabolism and pharmacokinetics, 2017-01, Vol.32 (1), p.S89-S89

2017

Volltextzugriff (PDF)

Population Pharmacokinetic Analysis of Fluconazole To Predict Therapeutic Outcome in Burn Patients with Candida Infection

Antimicrobial Agents and Chemotherapy, 2013-02, Vol.57 (2), p.1006-1011

2013

Volltextzugriff (PDF)

Pharmacokinetic–pharmacodynamic model of fimasartan applied to predict the influence of a high fat diet on its blood pressure-lowering effect in healthy subjects

European journal of clinical pharmacology, 2013, Vol.69 (1), p.11-20

2013

Volltextzugriff (PDF)

Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection

Clinical gastroenterology and hepatology, 2020-12, Vol.18 (13), p.3043-3045.e1

2020

Volltextzugriff (PDF)

The Safety and Pharmacokinetics of Cyanidin-3-Glucoside after 2-Week Administration of Black Bean Seed Coat Extract in Healthy Subjects

The Korean Journal of Physiology & Pharmacology, 2012, 16(4), , pp.249-253

2012

Volltextzugriff (PDF)

Pharmacokinetics and safety of evogliptin in hepatically impaired patients

British journal of clinical pharmacology, 2021-07, Vol.87 (7), p.2757-2766

2021

Volltextzugriff (PDF)

Comparison of the Pharmacokinetic–Pharmacodynamic Relationships of Two Darbepoetin Alfa Formulations in Healthy Male Volunteers

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2019-02, Vol.33 (1), p.101-112

2019

Volltextzugriff (PDF)

Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation

Scientific reports, 2017-11, Vol.7 (1), p.16276-10, Article 16276

2017

Volltextzugriff (PDF)

The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male

Drug design, development and therapy, 2019-09, Vol.13, p.3151-3159

2019

Volltextzugriff (PDF)

Simulation of PET scan timings for receptor occupancy studies of CNS drugs: a simple fixed-time design performed as well as scattered time point designs

European journal of clinical pharmacology, 2015-11, Vol.71 (11), p.1333-1339

2015

Volltextzugriff (PDF)

Use of a Target‐Mediated Drug Disposition Model to Predict the Human Pharmacokinetics and Target Occupancy of GC 1118, an Anti‐epidermal Growth Factor Receptor Antibody

Basic & clinical pharmacology & toxicology, 2017-03, Vol.120 (3), p.243-249

2017

Volltextzugriff (PDF)

Physiologically-based pharmacokinetic predictions of intestinal BCRP

The Korean journal of physiology & pharmacology, 2018-05, Vol.22 (3), p.321-329

2018

Volltextzugriff (PDF)

Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans

The Korean journal of physiology & pharmacology, 2018, Vol.22 (3), p.321-329

2018

Volltextzugriff (PDF)

Comparison of biosimilar flgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers

Drug design, development and therapy, 2018-01, Vol.10, p.2381

2018

Volltextzugriff (PDF)

Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects

Translational and Clinical Pharmacology, 2020, 28(1), , pp.55-65

2020

Volltextzugriff (PDF)

Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial

Yonsei Medical Journal, 2016, 57(6), , pp.1354-1360

2016

Volltextzugriff (PDF)

Saturable human neopterin response to interferon-[alpha] assessed by a pharmacokinetic-pharmacodynamic model

Journal of translational medicine, 2013-10, Vol.11 (1), p.240-240

2013

Volltextzugriff (PDF)

1 – 25 von 67

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(63)

Publikationsform

Artikel
(67)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(31)
Humans
(23)
Pharmacokinetics
(22)
Male
(19)
Pharmacology & Pharmacy
(19)
Adult
(15)
Middle Aged
(13)
Young Adult
(12)
Pharmacology
(11)
Physical Sciences
(11)
Technology
(11)
Drug Dosages
(10)
Female
(10)
Pharmacodynamics
(10)
Chemistry
(9)
Chemistry, Physical
(8)
Original
(8)
Materials Science
(7)
Materials Science, Multidisciplinary
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics, pharmacodynamics, and safety of izuforant, an H4R inhibitor, in healthy subjects: A phase I single and multiple ascending dose study

Pharmacokinetic and pharmacodynamic drug–drug interactions between evogliptin and empagliflozin or dapagliflozin in healthy male volunteers

Comparative Pharmacokinetic Analysis of Thiamine and Its Phosphorylated Metabolites Administered as Multivitamin Preparations

Population Pharmacokinetic Analysis of Piperacillin in Burn Patients

Population Pharmacokinetic Analysis of Colistin in Burn Patients

Evaluation of pharmacokinetic interactions between lobeglitazone, empagliflozin, and metformin in healthy subjects

Bortezomib pharmacokinetics in tumor response and peripheral neuropathy in multiple myeloma patients receiving bortezomib-containing therapy

Use of a Target‐Mediated Drug Disposition Model to Predict the Human Pharmacokinetics and Target Occupancy of GC1118, an Anti‐epidermal Growth Factor Receptor Antibody

Application of target-mediated drug disposition model to predict human pharmacokinetics and target occupancy of GC1118, an anti-epidermal growth factor receptor antibody

Population Pharmacokinetic Analysis of Fluconazole To Predict Therapeutic Outcome in Burn Patients with Candida Infection

Pharmacokinetic–pharmacodynamic model of fimasartan applied to predict the influence of a high fat diet on its blood pressure-lowering effect in healthy subjects

Efficacy of Lenvervimab, a Recombinant Human Immunoglobulin, in Treatment of Chronic Hepatitis B Virus Infection

The Safety and Pharmacokinetics of Cyanidin-3-Glucoside after 2-Week Administration of Black Bean Seed Coat Extract in Healthy Subjects

Pharmacokinetics and safety of evogliptin in hepatically impaired patients

Comparison of the Pharmacokinetic–Pharmacodynamic Relationships of Two Darbepoetin Alfa Formulations in Healthy Male Volunteers

Population pharmacokinetics of remifentanil in critically ill patients receiving extracorporeal membrane oxygenation

The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male

Simulation of PET scan timings for receptor occupancy studies of CNS drugs: a simple fixed-time design performed as well as scattered time point designs

Use of a Target‐Mediated Drug Disposition Model to Predict the Human Pharmacokinetics and Target Occupancy of GC 1118, an Anti‐epidermal Growth Factor Receptor Antibody

Physiologically-based pharmacokinetic predictions of intestinal BCRP

Physiologically-based pharmacokinetic predictions of intestinal BCRP-mediated drug interactions of rosuvastatin in Koreans

Comparison of biosimilar flgrastim with a reference product: pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers

Evaluation of pharmacokinetic interactions between amoxicillin, clarithromycin, and the potassium-competitive acid blocker YH4808 in healthy subjects

Immunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial

Saturable human neopterin response to interferon-[alpha] assessed by a pharmacokinetic-pharmacodynamic model

Suchergebnisse filtern